ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 126 filers reported holding ACCELERON PHARMA INC in Q4 2015. The put-call ratio across all filers is 2.00 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $24,955,000 | -9.4% | 145,000 | -33.9% | 0.49% | -0.4% |
| Q2 2021 | $27,545,000 | -7.5% | 219,500 | 0.0% | 0.49% | -21.9% |
| Q1 2021 | $29,766,000 | -44.8% | 219,500 | -47.9% | 0.63% | -41.3% |
| Q4 2020 | $53,942,000 | +13.7% | 421,619 | 0.0% | 1.07% | -7.7% |
| Q3 2020 | $47,445,000 | +18.1% | 421,619 | 0.0% | 1.16% | -1.3% |
| Q2 2020 | $40,168,000 | +30.3% | 421,619 | +22.9% | 1.17% | +19.6% |
| Q1 2020 | $30,825,000 | -57.6% | 343,000 | -75.0% | 0.98% | -57.8% |
| Q4 2019 | $72,618,000 | +40.8% | 1,369,625 | +4.9% | 2.32% | +10.2% |
| Q3 2019 | $51,567,000 | -3.8% | 1,305,174 | 0.0% | 2.10% | +9.1% |
| Q2 2019 | $53,617,000 | -8.3% | 1,305,174 | +4.0% | 1.93% | -14.1% |
| Q1 2019 | $58,453,000 | -3.2% | 1,255,174 | -9.5% | 2.24% | -7.3% |
| Q4 2018 | $60,384,000 | -5.6% | 1,386,541 | +24.1% | 2.42% | +5.5% |
| Q3 2018 | $63,963,000 | +17.0% | 1,117,651 | -0.8% | 2.29% | +19.3% |
| Q2 2018 | $54,672,000 | +127.4% | 1,126,800 | +83.2% | 1.92% | +130.5% |
| Q1 2018 | $24,047,000 | -7.9% | 615,000 | 0.0% | 0.83% | -18.9% |
| Q4 2017 | $26,101,000 | +13.7% | 615,000 | 0.0% | 1.03% | -0.7% |
| Q3 2017 | $22,952,000 | +146.0% | 615,000 | +74.0% | 1.03% | +160.5% |
| Q1 2016 | $9,329,000 | -10.4% | 353,491 | +65.6% | 0.40% | -5.9% |
| Q4 2015 | $10,410,000 | – | 213,491 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |